Quoin Pharmaceuticals, Ltd.

QNRXNASDAQHealthcare● Active

$4.60

+$0.03(+0.66%)

Market Cap$2705564

P/E Ratio—

52W High$41.8

52W Low$4.11

Avg Volume98K

Open$4.50

Beta1.57

Revenue Financials Earnings

Quoin Pharmaceuticals, Ltd. (QNRX) Revenue

Annual & quarterly revenue history · segment & region breakdown

QNRX · revenue · updated Jun 10, 2026

Core revenue metrics

Trailing 12 months

Quoin Pharmaceuticals, Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY —

Price / sales

—

mktCap ÷ TTM rev

Revenue per day

—

Est. TTM ÷ 365

Revenue / employee

$0K

3 employees

—

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · Quoin Pharmaceuticals, Ltd. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

– · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth

QNRX revenue by year · QNRX revenue history · QNRX annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Quoin Pharmaceuticals, Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Quoin Pharmaceuticals, Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Quoin Pharmaceuticals, Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

QNRX revenue · 4 questions

QNRX's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

QNRX revenueQNRX annual revenuewhat is QNRX revenueQNRX TTM revenue

▸ Source: FMP · Quoin Pharmaceuticals, Ltd. SEC filings · GAAP · Quoin Pharmaceuticals, Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026